Education
About Us
Working with TipRanks
Follow Us
Kangji Medical Holdings Limited (HK:9997)
:9997
RESEARCH TOOLSreports
Total Valuation
Kangji Medical Holdings Limited has a market cap or net worth of HK$9.95B. The enterprise value is HK$6.08B.
Market CapHK$9.95B
Enterprise ValueHK$6.08B
Share Statistics
Kangji Medical Holdings Limited has 1,207,994,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,207,994,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kangji Medical Holdings Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 18.58%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)18.58%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee1.00M
Profits Per Employee577.40K
Employee Count1,007
Asset Turnover0.35
Inventory Turnover1.95
Valuation Ratios
The current PE Ratio of Kangji Medical Holdings Limited is 15.7. Kangji Medical Holdings Limited’s PEG ratio is ―.
PE Ratio15.7
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.63
Price to FCF0.00
Price to Operating Cash Flow16.15
PEG Ratio―
Income Statement
In the last 12 months, Kangji Medical Holdings Limited had revenue of 1.01B and earned 581.44M in profits. Earnings per share was 0.49.
Revenue1.01B
Gross Profit797.65M
Operating Income592.69M
Pretax Income684.83M
Net Income581.44M
EBITDA562.61M
Earnings Per Share (EPS)0.49
Cash Flow
In the last 12 months, operating cash flow was 560.10M and capital expenditures -55.29M, giving a free cash flow of 504.81M billion.
Operating Cash Flow560.10M
Free Cash Flow504.81M
Free Cash Flow per Share0.42
Dividends & Yields
Kangji Medical Holdings Limited pays an annual dividend of HK$0.261, resulting in a dividend yield of 3.1%
Dividend Per ShareHK$0.261
Dividend Yield3.1%
Payout Ratio48.41%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.59
52-Week Price Change56.71%
50-Day Moving Average8.06
200-Day Moving Average6.88
Relative Strength Index (RSI)59.54
Average Volume (3m)2.39M
Important Dates
Kangji Medical Holdings Limited upcoming earnings date is Aug 21, 2025, TBA (Confirmed).
Last Earnings DateMar 24, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateMay 27, 2025
Financial Position
Kangji Medical Holdings Limited as a current ratio of 7.92, with Debt / Equity ratio of 0.13%
Current Ratio7.92
Quick Ratio7.50
Debt to Market Cap0.00
Net Debt to EBITDA-2.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Kangji Medical Holdings Limited has paid 113.56M in taxes.
Income Tax113.56M
Effective Tax Rate0.17
Enterprise Valuation
Kangji Medical Holdings Limited EV to EBITDA ratio is 10.31, with an EV/FCF ratio of 11.50.
EV to Sales5.75
EV to EBITDA10.31
EV to Free Cash Flow11.50
EV to Operating Cash Flow10.36
Balance Sheet
Kangji Medical Holdings Limited has HK$1.24B in cash and marketable securities with HK$3.52M in debt, giving a net cash position of -HK$1.24B billion.
Cash & Marketable SecuritiesHK$1.24B
Total DebtHK$3.52M
Net Cash-HK$1.24B
Net Cash Per Share-HK$1.03
Tangible Book Value Per ShareHK$2.24
Margins
Gross margin is 79.08%, with operating margin of 58.76%, and net profit margin of 57.65%.
Gross Margin79.08%
Operating Margin58.76%
Pretax Margin67.90%
Net Profit Margin57.65%
EBITDA Margin55.78%
EBIT Margin53.57%
Analyst Forecast
The average price target for Kangji Medical Holdings Limited is HK$9.94, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$9.94
Price Target Upside18.10% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast7.13%
EPS Growth Forecast13.39%